# Anti-Affirmative Action Groups Target Congressional Black Caucus Scholarships > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/anti-affirmative-action-groups-cannabis-policy-updates/ > **Published:** 2026-04-03T22:01:20-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:30:41-04:00 > **Clinical Summary:** Explore how anti affirmative action groups cannabis policy impacts the Congressional Black Caucus and medical cannabis advocacy developments. --- ✦ New CED Clinical Relevance  #70Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News  |  CED Clinic AntiAffirmativeActionGroups Why This Matters This item covers developments relevant to [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/) and clinical practice. Clinicians monitoring evidence in this area should review the source material. Clinical Summary Summary not available. See source for full context. Dr. Caplan’s Take “This is a development worth tracking. The clinical implications will become clearer as more evidence accumulates.” Clinical Perspective 🧠 Clinicians should review this item in the context of their current practice and patient population. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-industry/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Anti-Affirmative%20Action%20Groups%20are%20Now%20Coming%20for%20the%20Congressional%20Black%20Caucus...%20%40drcaplan&url=https%3A//www.theroot.com/anti-affirmative-action-groups-are-now-coming-for-the-c-2000098383)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//www.theroot.com/anti-affirmative-action-groups-are-now-coming-for-the-c-2000098383)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Anti-Affirmative%20Action%20Groups%20are%20Now%20Coming%20for%20the%20Congressional%20Black%20Caucus...%20--%20via%20%40drcaplan.bsky.social%20https%3A//www.theroot.com/anti-affirmative-action-groups-are-now-coming-for-the-c-2000098383)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://www.theroot.com/anti-affirmative-action-groups-are-now-coming-for-the-c-2000098383](https://www.theroot.com/anti-affirmative-action-groups-are-now-coming-for-the-c-2000098383) Table of Contents - [FAQ](#FAQ)[What is the clinical relevance rating of this cannabis news?](#What_is_the_clinical_relevance_rating_of_this_cannabis_news) - [What type of cannabis-related content does this article cover?](#What_type_of_cannabis-related_content_does_this_article_cover) - [Why should clinicians pay attention to this particular cannabis news?](#Why_should_clinicians_pay_attention_to_this_particular_cannabis_news) - [What does the “New” designation mean for this article?](#What_does_the_8220New8221_designation_mean_for_this_article) - [How does this article relate to clinical cannabis practice?](#How_does_this_article_relate_to_clinical_cannabis_practice) - [Related](#Related) ## FAQ #### What is the clinical relevance rating of this cannabis news? This article has been assigned CED Clinical Relevance #70, indicating “Notable Clinical Interest.” This rating suggests the content contains emerging findings or policy developments that healthcare professionals should monitor closely. #### What type of cannabis-related content does this article cover? Based on the tags, this article appears to cover anti-cannabis perspectives and affirmative action groups related to cannabis policy. The content seems to focus on organizational or advocacy aspects rather than direct [medical research](https://cedclinic.com/cb2-receptor-agonist-parkinsons/). #### Why should clinicians pay attention to this particular cannabis news? The “Notable Clinical Interest” designation indicates this contains emerging findings or policy developments worth monitoring. Such developments can impact clinical practice, patient access, or regulatory frameworks affecting [medical cannabis](https://cedclinic.com/therapeutic-benefits-of-thc/) use. #### What does the “New” designation mean for this article? The “New” tag indicates this is recently published or updated content. This suggests the information represents current developments in the cannabis policy or advocacy landscape that clinicians should be aware of. #### How does this article relate to clinical cannabis practice? While the article appears to focus on policy and advocacy groups, such developments can influence the regulatory environment for medical cannabis. Understanding these dynamics helps clinicians stay informed about factors that may affect their ability to recommend or prescribe cannabis treatments. [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [New research suggests cannabinoids like CBD and CBG may help improve fatty liver disease.](https://cedclinic.com/cannabinoids-fatty-liver-clinical-relevance/) Discover emerging research on cannabinoids CBD and CBG and their potential benefits for [fatty liver disease](https://cedclinic.com/cannabinoid-receptor-type-1-antagonist-obesity-steatohepatitis/). [Read More](https://cedclinic.com/cannabinoids-fatty-liver-clinical-relevance/) [Medicinal cannabis export licenses take 6.4 working days in 2026 – New Zealand Doctor](https://cedclinic.com/medicinal-cannabis-export-licensing-process-2026/) Learn about the latest timelines for medicinal cannabis export licenses in 2026 and regulatory updates. [Learn More](https://cedclinic.com/medicinal-cannabis-export-licensing-process-2026/) [Happy 4/20! As Co-Chair of the Congressional Cannabis Caucus, I am proud to introduce …](https://cedclinic.com/congressional-cannabis-caucus-update-2026/) Insights from the Congressional Cannabis Caucus on cannabis policy and advocacy efforts in 2026. [Explore Now](https://cedclinic.com/congressional-cannabis-caucus-update-2026/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).